Marc Since

804 total citations
32 papers, 529 citations indexed

About

Marc Since is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Marc Since has authored 32 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 16 papers in Organic Chemistry and 11 papers in Pharmacology. Recurrent topics in Marc Since's work include Cholinesterase and Neurodegenerative Diseases (10 papers), Computational Drug Discovery Methods (6 papers) and Alzheimer's disease research and treatments (5 papers). Marc Since is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (10 papers), Computational Drug Discovery Methods (6 papers) and Alzheimer's disease research and treatments (5 papers). Marc Since collaborates with scholars based in France, Italy and Luxembourg. Marc Since's co-authors include Aurélie Malzert‐Fréon, Sophie Corvaisier, Christophe Rochais, Patrick Dallemagne, Cédric Lecoutey, Loïc Le Pluart, Thomas Fréret, Anne‐Claire Groo, Audrey Davis and Michel Boulouard and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and International Journal of Molecular Sciences.

In The Last Decade

Marc Since

28 papers receiving 521 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc Since France 14 190 180 158 123 100 32 529
Aurélie Malzert‐Fréon France 16 156 0.8× 243 1.4× 125 0.8× 81 0.7× 174 1.7× 40 677
Farhad Eisvand Iran 13 211 1.1× 190 1.1× 76 0.5× 51 0.4× 32 0.3× 26 602
Catia Cornacchia Italy 14 125 0.7× 233 1.3× 100 0.6× 33 0.3× 39 0.4× 17 576
Nirupam Das India 11 247 1.3× 134 0.7× 73 0.5× 55 0.4× 47 0.5× 37 486
Ichiro Hijikuro Japan 11 150 0.8× 141 0.8× 92 0.6× 52 0.4× 79 0.8× 24 401
Akash Marathakam India 10 97 0.5× 121 0.7× 126 0.8× 61 0.5× 16 0.2× 19 381
M. Arockia Babu India 13 129 0.7× 135 0.8× 60 0.4× 72 0.6× 23 0.2× 62 404
M. Alaraby Salem Egypt 14 182 1.0× 122 0.7× 92 0.6× 80 0.7× 17 0.2× 21 696
Xiaojun Gou China 17 194 1.0× 353 2.0× 64 0.4× 30 0.2× 18 0.2× 38 800
Subham Das India 14 170 0.9× 165 0.9× 59 0.4× 83 0.7× 11 0.1× 42 563

Countries citing papers authored by Marc Since

Since Specialization
Citations

This map shows the geographic impact of Marc Since's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Since with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Since more than expected).

Fields of papers citing papers by Marc Since

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Since. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Since. The network helps show where Marc Since may publish in the future.

Co-authorship network of co-authors of Marc Since

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Since. A scholar is included among the top collaborators of Marc Since based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Since. Marc Since is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Khoumeri, Omar, Sébastien Hutter, Nicolas Primas, et al.. (2024). Synthesis of Nitrostyrylthiazolidine-2,4-dione Derivatives Displaying Antileishmanial Potential. Pharmaceuticals. 17(7). 878–878.
4.
Ramos, Isbaal, María Valcárcel, Achille Gravanis, et al.. (2023). Design, synthesis and biological characterization of novel activators of the TrkB neurotrophin receptor. European Journal of Medicinal Chemistry. 248. 115111–115111. 5 indexed citations
5.
Since, Marc, Sophie Corvaisier, Julien Cardin, et al.. (2023). A Biomimetic Multiparametric Assay to Characterise Anti-Amyloid Drugs. International Journal of Molecular Sciences. 24(23). 16982–16982.
6.
Hutter, Sébastien, Jean‐François Franetich, Aurélie Malzert‐Fréon, et al.. (2023). Novel thienopyrimidones targeting hepatic and erythrocytic stages of Plasmodium parasites with increased microsomal stability. European Journal of Medicinal Chemistry. 261. 115873–115873. 2 indexed citations
7.
Primas, Nicolas, Sandra Bourgeade‐Delmas, Sébastien Hutter, et al.. (2022). Improving Aqueous Solubility and In Vitro Pharmacokinetic Properties of the 3-Nitroimidazo[1,2-a]pyridine Antileishmanial Pharmacophore. Pharmaceuticals. 15(8). 998–998. 3 indexed citations
8.
Hutter, Sébastien, Nadia Amanzougaghene, Jean‐François Franetich, et al.. (2022). Synthesis of antiplasmodial 2-aminothieno[3,2-d]pyrimidin-4(3H)-one analogues using the scaffold hopping strategy. European Journal of Medicinal Chemistry. 241. 114619–114619. 5 indexed citations
9.
Since, Marc, Julien Cardin, Sophie Corvaisier, et al.. (2021). β-Amyloid peptide interactions with biomimetic membranes: A multiparametric characterization. International Journal of Biological Macromolecules. 181. 769–777. 7 indexed citations
10.
Groo, Anne‐Claire, Céline Picard, Audrey Davis, et al.. (2020). Pharmacotechnical Development of a Nasal Drug Delivery Composite Nanosystem Intended for Alzheimer’s Disease Treatment. Pharmaceutics. 12(3). 251–251. 60 indexed citations
11.
Lecoutey, Cédric, Audrey Davis, Marc Since, et al.. (2020). Pleiotropic prodrugs: Design of a dual butyrylcholinesterase inhibitor and 5-HT6 receptor antagonist with therapeutic interest in Alzheimer’s disease. European Journal of Medicinal Chemistry. 210. 113059–113059. 25 indexed citations
12.
Groo, Anne‐Claire, Marc Since, Émilie Brotin, et al.. (2020). Pyridoclax-loaded nanoemulsion for enhanced anticancer effect on ovarian cancer. International Journal of Pharmaceutics. 587. 119655–119655. 16 indexed citations
13.
Since, Marc, et al.. (2020). Antipsychotic lurasidone: Behavioural and pharmacokinetic data in C57BL/6 mice. Pharmacology Biochemistry and Behavior. 194. 172933–172933. 5 indexed citations
14.
Lecoutey, Cédric, Audrey Davis, Marc Since, et al.. (2019). Inhibiting Acetylcholinesterase to Activate Pleiotropic Prodrugs with Therapeutic Interest in Alzheimer’s Disease. Molecules. 24(15). 2786–2786. 20 indexed citations
15.
Lecoutey, Cédric, Marc Since, Audrey Davis, et al.. (2019). Novel multi target-directed ligands targeting 5-HT4 receptors with in cellulo antioxidant properties as promising leads in Alzheimer's disease. European Journal of Medicinal Chemistry. 182. 111596–111596. 12 indexed citations
16.
Jourdan, Jean‐Pierre, Marc Since, Laïla El Kihel, et al.. (2017). Benzylphenylpyrrolizinones with Anti‐amyloid and Radical Scavenging Effects, Potentially Useful in Alzheimer's Disease Treatment. ChemMedChem. 12(12). 913–916. 9 indexed citations
17.
Tournier, Benjamin B., Thomas Cailly, Cédric Lecoutey, et al.. (2016). Synthesis and evaluation of novel serotonin 4 receptor radiotracers for single photon emission computed tomography. European Journal of Medicinal Chemistry. 116. 90–101. 8 indexed citations
18.
Groo, Anne‐Claire, et al.. (2016). Comparison of 2 strategies to enhance pyridoclax solubility: Nanoemulsion delivery system versus salt synthesis. European Journal of Pharmaceutical Sciences. 97. 218–226. 16 indexed citations
19.
Since, Marc, et al.. (2015). Evaluation of the versatile character of a nanoemulsion formulation. International Journal of Pharmaceutics. 498(1-2). 49–65. 49 indexed citations
20.
Since, Marc, et al.. (2013). New orally effective 3-(2-nitro)phenylpropanamide analgesic derivatives: Synthesis and antinociceptive evaluation. European Journal of Medicinal Chemistry. 69. 728–734. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aurélie Malzert‐Fréon Breakdown of academic impact, for papers by Farhad Eisvand Breakdown of academic impact, for papers by Catia Cornacchia Breakdown of academic impact, for papers by Nirupam Das Breakdown of academic impact, for papers by Ichiro Hijikuro Breakdown of academic impact, for papers by Akash Marathakam Breakdown of academic impact, for papers by M. Arockia Babu Breakdown of academic impact, for papers by M. Alaraby Salem Breakdown of academic impact, for papers by Xiaojun Gou Breakdown of academic impact, for papers by Subham Das
Rankless by CCL
2026